logo

For the Inventor, By the Inventor

Philadelphia, PA, United States of America

Institute for Cancer Research


USPTO Granted Patents = 64



Forward Citations = 99

Loading Chart...
Loading Chart...

106 inventors (with patents filed for the assignee):

goldMedal Wafik S El-Deiry (13 out of 25 patents)

silverMedal Timothy J Yen (6 out of 7 patents)

bronzeMedal Mark D Andrake (5 out of 5 patents)

4.  Xiaobing Tian (5 out of 5 patents)

5.  Vikram Bhattacharjee (4 out of 8 patents)

6.  Amriti R Lulla (4 out of 4 patents)

7.  Alfonso Bellacosa (3 out of 8 patents)

8.  Neil Beeharry (3 out of 3 patents)

9.  Anna Marie Skalka (3 out of 6 patents)

10.  Robert G Uzzo (3 out of 4 patents)

11.  George W Merkel (2 out of 2 patents)

12.  Jonathan Chernoff (2 out of 2 patents)

13.  Hoi Yee Chow (2 out of 2 patents)

14.  Shengliang Zhang (2 out of 2 patents)

15.  Rossella Tricarico (2 out of 3 patents)


Core Competencies:
Genetically Modified NK-92 Cells
Bronchoscope Tip Marker
Netrin G1 Biomarker
EGFR Somatic Mutations
miRNA Targeting CDK4/CDK6
Human Chorionic Gonadotropin Peptides
Poly(ADP-Ribose) Polymerase Inhibitors
Carbon Nanotube Biosensors
HIV-1 Integrase Inhibitors
Surgical Clamp Technology
Tumor Treatment Efficacy
Fluorescence Molecular Tomography

64 patents:

1. 12384852 - Genetically modified NK-92 cells having a safety switch (2025-08-12),
2. 12377235 - Multipurpose device (2025-08-05),
3. 12369787 - Bronchoscope tip marker for orientation of radial endobronchial ultrasound probe (2025-07-29),
4. 12344599 - Prodigiosin analogs and methods of use (2025-07-01),
5. 12240897 - Treatment of non-alcoholic steatohepatitis (NASH) with IL-27 antibody (2025-03-04),
6. 12226105 - Tensionable surgical clamp (2025-02-18),
7. 12098428 - Frequent EGFR and NTRK somatic mutations in colorectal cancer (CRC) with microsatellite instability (MSI) (2024-09-24),
8. 12098193 - Netrin G1 as a biomarker for enhancing tumor treatment efficacy (2024-09-24),
9. 12071622 - miR-3132 upregulation of the trail pathway and apoptotic activity in cancer cells (2024-08-27),
10. 11993589 - Prodigiosin analogs and methods of use (2024-05-28),
11. 11944319 - Tensionable surgical clamp (2024-04-02),
12. 11859183 - Treatment of tumors with miRNA targeting CDK4/CDK6 (2024-01-02),
13. 11697674 - Human chorionic gonadotropin variant peptides and treatment of breast cancer (2023-07-11),
14. 11587229 - Retained surgical items (2023-02-21),
15. 11578370 - Methods for diagnosis and treatment of patients having solid tumors (2023-02-14),
The Institute for Cancer Research is a non-profit research organization dedicated to studying and finding effective treatments and therapies for cancer. With a team of dedicated scientists, doctors, and researchers, the institute conducts groundbreaking research to better understand the complexities of cancer and develop innovative approaches for prevention, early detection, and treatment. Visit their website to learn more about their exciting discoveries and ongoing research initiatives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
64 Patents

#30 in Philadelphia, PA

#214 in Pennsylvania

#5,499 in US

#11,187 in the World

...
Philadelphia, PA, United States of America

Institute for Cancer Research

Forward Citations = 99

106 inventors:

goldMedal Wafik S El-Deiry (13 out of 25 patents)

silverMedal Timothy J Yen (6 out of 7 patents)

bronzeMedal Mark D Andrake (5 out of 5 patents)

4.  Xiaobing Tian (5 out of 5 patents)

5.  Vikram Bhattacharjee (4 out of 8 patents)

Please report any incorrect information to support@idiyas.com
Loading…